Share Name Share Symbol Market Type Share ISIN Share Description
Science Group Plc LSE:SAG London Ordinary Share GB00B39GTJ17 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 445.00 12,663 08:00:00
Bid Price Offer Price High Price Low Price Open Price
430.00 460.00 445.00 445.00 445.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 73.66 6.39 16.90 26.3 183
Last Trade Time Trade Type Trade Size Trade Price Currency
16:27:27 O 6,500 449.00 GBX

Science (SAG) Latest News

More Science News
Science Investors    Science Takeover Rumours

Science (SAG) Discussions and Chat

Science Forums and Chat

Date Time Title Posts
30/7/202123:29SCIENCE GROUP223
24/7/201807:48Science Group (SAG) One to Watch on Monday 2
21/4/201716:40SAGENTIA PLC600
19/1/201710:15Shareholder Action Groups4

Add a New Thread

Science (SAG) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Science trades in real-time

Science (SAG) Top Chat Posts

Science Daily Update: Science Group Plc is listed in the Support Services sector of the London Stock Exchange with ticker SAG. The last closing price for Science was 445p.
Science Group Plc has a 4 week average price of 385p and a 12 week average price of 345p.
The 1 year high share price is 460p while the 1 year low share price is currently 235p.
There are currently 41,135,326 shares in issue and the average daily traded volume is 127,965 shares. The market capitalisation of Science Group Plc is £183,052,200.70.
varies: life of crime Thank you very much indeed for digging out this information and posting it. My recollection of Toumaz and the Sensium division is very hazy and I am interested to be reminded of what actually happened. SAG is unlikely, as you say, to derive any benefit from the Sensium royalties but I am making profits (on paper, of course) on my SAG shares that far outweigh my losses on Toumaz/TST and so have been lucky. For the moment every pronouncement from SAG is more encouraging than the last and the directors do seem very capable.
life of crime: varies, they sold off the healthcare division, Sensium, for £1.3 million, which was a giveaway. As you said, there was a future royalty (for 10 years) but that was 5 years ago and I doubt they have made a penny from it. From memory, the royalty rate was tiny anyway. If the board could have delivered on their justification for the sale, to concentrate on the audio business, it might have been worth it, but we know how well that went! It is a shame they just did not licence the health technology to a bigger firm and transfer the relevant staff in return for a permanent royalty. However, they just wanted rid of it in return for peanuts upfront. Another stupid decision by the useless clowns that nearly ran Frontier into the ground. The ease with which SAG have turned Frontier around says it all. hTTps://
life of crime: I have only just seen the latest report. It was an excellent update and it is good to see how the share price has responded. It looks as if Frontier has really bedded in and what was a business that always had potential is now fulfilling it, thanks to the new management. I am very pleased with this investment, in stark comparison with the basket case that was Frontier under the previous directors. The full-year report should make for good reading. PS. Another good set of results from one of my other investments today, Lloyds Bank. Their interim dividend is paid out on 13 September and that was the only thing that was missing from Science Group's excellent update. It sounds like SAG want to sit on their cash while they look for further acquisitions instead, but I still expect a final dividend next year.
life of crime: Monday's announcement about paying Imagination Technologies $6 million as a final one-off royalty makes sense and is a sensible use of their cash pile. It is good to hear that this is expected to be earnings enhancing straightaway. Frontier was a wise acquisition and opened SAG up to a growing market via digital radio. This can only get bigger as more EU nations take advantage of the legislation that allows them to phase out analogue or make DAB compulsory in all new sets, like France has done. Definitely a share to hang onto and may make SAG a target themselves one day and for a decent premium, as you would expect for a well run company with some attractive business divisions.
varies: Martin Radcliffe made a great success of Microgen which was re-organised a few years ago with part of the business sold off and the remainder now trading as Aptitude. I believe that it was at about that time that MR moved to SAG. He strikes me as a good man to follow.
varies: There seems to have been a misunderstanding when Mr. Vohra was appointed as CFO three months ago as to the scope of his role at SAG and this has proved more limited than he had hoped. He may perhaps have had other disagreements too with the chairman and the other directors. It will be interesting to see where Mr. Vohra goes next. Certainly SAG has proved a very successful company and I feel confident that its present management system will continue to yield good results.
life of crime: Something more relevant to Frontier/SAG than my previous post: hTTps:// It is good to see the digital radio sector promoting the advantages of DAB+. It was interesting to learn that only 35-40% of UK DAB users can access DAB+ and its many extra stations. I suspect that is because DAB adaptation took off in the UK before anywhere else nearly 20 years ago, when Pure launched the first <£100 digital radio, the iconic Evoke 1. That means there are a lot of legacy sets still out there from the pre-DAB+ era. This leaves a real opportunity for the industry to target those existing DAB customers over here to upgrade their sets to DAB+. The sooner the UK follows the lead of France and mandates that all future radios must include FM/DAB+ as standard, the better. Either way, this promotion can only help DAB+ sales, which is good for Frontier/SAG.
life of crime: I agree Dav, I do not trust tipsters either. However, if it adds 20p to the share price I am not complaining! SAG will get to 500p through its own efforts. To all SAG holders, enjoy what is left of the summer solstice.
life of crime: Here is the tip: Perhaps surprisingly at the advanced seminar the top vote went to Science Group (SAG) as a lovely isa tuckaway. It’s one of those shares that goes unnoticed/untouched except for my advanced group! The shares have strong momentum off the back of a bullish trading update and strong results. Revenue, profit and operating margins are all up. There is plenty of cash and management has skin in the game and bullish on prospects reporting operating profit likely to be 30pc higher in H1 2021. Downside? Not too many market makers in this one and so the spread can go to the wide side but usually it is fairly easy to deal well inside it. For example today the buy price looks like 410. It is actually 395!A nice idea for a safeish isa tuckaway for those with patience. Shares have a history of rising, then consolidating, (price not moving much) then rising again. Looks like it is in a consolidating stage before another step up, targeting 450p then 500p.
truffle: The company has re-purchased 75,000 shares in two trades during the past week which would seem to put a pretty good base on the share price in what is a normally quite thinly traded market. Encouraging.
Science share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210731 17:28:28